BioAge Labs
Yahoo Finance • 9 hours ago
BIOA SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. (BIOA)
RADNOR, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern... Full story
Yahoo Finance • 10 hours ago
ROSEN, NATIONAL TRIAL LAWYERS, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge’s registration statement for the ini... Full story
Yahoo Finance • 13 hours ago
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference
RICHMOND, Calif., Feb. 20, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (Nasdaq: BIOA) (“BioAge”, “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biolog... Full story
Yahoo Finance • 16 hours ago
March 10, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against BIOA
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of BioAge Labs, Inc. (NASDAQ: BIOA). Shareholders who purchased shares of BIOA during the class period listed are encouraged to c... Full story
Yahoo Finance • 21 hours ago
BIOA SECURITIES LAWSUIT: BioAge Investors that Lost Money may have been affected by Misconduct -- Contact BFA Law by March 10 Class Action Deadline (NASDAQ:BIOA)
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for potential violat... Full story
Yahoo Finance • 2 days ago
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BioAge Labs, Inc. (“BioAge” o... Full story
Yahoo Finance • 2 days ago
BioAge Labs (BIOA) Abandons Obesity Drug Amid Shareholder Lawsuit – Hagens Berman
SAN FRANCISCO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) is abandoning development of its lead obesity candidate, azelaprag, just weeks after halting a Phase 2 trial. The biotech firm is pivoting to a preclinical... Full story
Yahoo Finance • 2 days ago
DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
LOS ANGELES, Feb. 19, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 2 days ago
DEADLINE ALERT for NXT, RVNC, REGN, BIOA: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
BENSALEM, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the d... Full story
Yahoo Finance • 2 days ago
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In BioAge To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in BioAg... Full story
Yahoo Finance • 2 days ago
BIOA STOCK NEWS: Robbins LLP Reminds BioAge Labs, Inc. Investors of the Pending Lead Plaintiff Deadline – March 10, 2025
SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQ: BIOA) registration sta... Full story
Yahoo Finance • 3 days ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Lawsuit – BIOA
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or the "Company") (NASDAQ: BIOA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover lo... Full story
Yahoo Finance • 3 days ago
BIOA SECURITIES ALERT: A Class Action has been Filed against BioAge Labs for Securities Violations – Contact BFA Law by March 10 Deadline (NASDAQ:BIOA)
NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for potential violat... Full story
Yahoo Finance • 4 days ago
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA
NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of stock of BioAge Labs, Inc. (NASDAQ: BIOA) pursuant and/or traceable to BioAge’s registration statement for the ini... Full story
Yahoo Finance • 4 days ago
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
SAN FRANCISCO, Feb. 17, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege the company misled investors about the... Full story
Yahoo Finance • 5 days ago
BIOA COURT NEWS: BioAge Labs has been Sued for Securities Violations; Contact BFA Law by March 10 if You Lost Money (NASDAQ:BIOA)
NEW YORK, Feb. 16, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for potential violat... Full story
Yahoo Finance • 6 days ago
Lead Plaintiff Deadline Approaching in BIOA: Kessler Topaz Meltzer & Check, LLP Reminds Investors A Securities Fraud Class Action Has Been Filed Against BioAge Labs, Inc. (BIOA)
RADNOR, Pa., Feb. 15, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern... Full story
Yahoo Finance • 7 days ago
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial – Hagens Berman
SAN FRANCISCO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is facing a class-action lawsuit from shareholders who allege the company misled investors about the... Full story
Yahoo Finance • 7 days ago
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
LOS ANGELES, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming March 10, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherw... Full story
Yahoo Finance • 7 days ago
BIOA SHAREHOLDER ACTION: BioAge Labs 76% Stock Drop Prompts Class Action; Contact BFA Law by March 10 if You Suffered Losses (NASDAQ:BIOA)
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and certain of its senior executives for potential violat... Full story
